Persistent URL of this record https://hdl.handle.net/1887/94582
In Collections
This item can be found in the following collections:
Rationale and design of the phase 2b clinical trials to study the effects of the partial adenosine A1-receptor agonist neladenoson bialanate in patients with chronic heart failure with reduced (PANTHEON) and preserved (PANACHE) ejection fraction
- All authors
- Voors, A.A.; Shah, S.J.; Bax, J.J.; Butler, J.; Gheorghiade, M.; Hernandez, A.F.; Kitzman, D.W.; McMurray, J.J.V.; Wirtz, A.B.; Lanius, V.; Laan, M. van der; Solomon, S.D.
- Date
- 2018-11-30
- Volume
- 20
- Issue
- 11
- Pages
- 1601 - 1610